COMP <GO>
STIM vs JNJ // NET PROFIT MARGIN
Neuronetics Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: STIM 1
— JNJ 9
▲ NET PROFIT MARGIN LEADER: JNJ
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
net-margins
-26.10%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STIM VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STIM | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.50% | 67.90% | -19.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.50% | -60.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.25% | 2.97% | -14.22 | JNJ | /fcf-yield <GO> |
| Operating Margin | -21.10% | 34.70% | -55.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -26.10% | 28.50% | -54.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 99.20% | 6.00% | +93.20 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 62.1 | -6.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $181.3M | $662.49B | -$662.31B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STIM REV | JNJ REV | STIM GROSS % | JNJ GROSS % | STIM FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $149.2M | $94.19B | 48.5% | 67.9% | -$20.4M | $19.70B |
| FY 2024 | $74.9M | $88.82B | 72.3% | 69.1% | -$31.0M | $19.84B |
| FY 2023 | $71.3M | $85.16B | — | — | -$32.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STIM // BETA —
JNJ // BETA 1.08